The Recall Desk

Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Filters

Agency

Category

Minimum severity

Clear filters

17501–17525 of 18009

  • ModerateFDA (Drugs)·D-173-2013·2013-03-06

    Amedra Recalls Dextroamphetamine Sulfate Capsules for Dissolution Failures

    Amedra Pharmaceuticals is recalling 10,968 bottles of Dextroamphetamine Sulfate Extended Release Capsules because they may not meet dissolution specifications over the product shelf life.

    Product
    Dextroamphetamine Sulfate Extended Release Capsules, 5 mg, 90 capsules, Rx only, Manufactured by Catalent Pharma Solutions for CorePharma, LLC Middlesex, NJ 08846 NDC 64720-329-09
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-170-2013·2013-03-06

    West-ward Recalls Belladonna Alkaloids Tablets Due to Foreign Substance

    West-ward Pharmaceutical Corp. is recalling Belladonna Alkaloids with Phenobarbital tablets because uncharacteristic black spots were found in the product.

    Product
    Belladonna Alkaloids (hyoscyamine sulfate, USP 0.1037 mg; atropine sulfate, USP 0.0194 mg; scopolamine HBr, USP 0.0065 mg) with Phenobarbital (USP 16.2 mg) Tablets, packaged in a) 1000-count tablets per bottle (NDC 0143-1140-10; b) 5000-count tablets per bottle (NDC…
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-178-2013·2013-03-06

    Dr. Reddy's Recalls Citalopram Tablets Due to Chemical Odor Complaints

    Dr. Reddy's is recalling 27,805 bottles of Citalopram tablets 10mg due to reports of a strong garlic or chemical smell.

    Product
    Citalopram tablets USP, 10mg, 30-count bottle, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Bachupalli, India 502 325, NDC 55111-342-30
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-171-2013·2013-03-06

    Amedra Recalls Dextroamphetamine Sulfate Capsules for Dissolution Failures

    Amedra Pharmaceuticals is recalling 1,176 bottles of Dextroamphetamine Sulfate Extended Release Capsules because they may not meet dissolution specifications.

    Product
    Dextroamphetamine Sulfate Extended Release Capsules, 5 mg, 90 capsules, Rx only, Manufactured by Catalent Pharma Solutions for CorePharma, LLC Middlesex, NJ 08846 NDC 64720-327-09
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-179-2013·2013-03-06

    Dr. Reddy's Recalls Citalopram Tablets Due to Chemical Odor Complaints

    Dr. Reddy's is recalling 86,093 bottles of Citalopram tablets due to reports of a strong garlic or chemical smell.

    Product
    Citalopram tablets USP, 20mg, 30-count bottle, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Bachupalli, India 502 325, NDC 55111-343-30
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-177-2013·2013-03-06

    Bayer Recalls Bronkaid Dual Action Formula Due to Labeling Errors

    Bayer Healthcare is recalling Bronkaid Dual Action Formula caplets because the carton label is missing a warning or Rx legend and other information.

    Product
    Bronkaid Dual Action Formula, Ephedrine Sulfate 25 mg/Bronchodilator, Guaifenesin 400 mg/Expectorant, a) 24 coated caplets per blister pack, UPC 300240537879, b) 60 coated caplets per blister pack, UPC 300240537855, Bayer HealthCare LLC, Consumer Care, P.O. Box 1910…
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-175-2013·2013-03-06

    Actavis Recalls BuPROPion Hydrochloride Tablets Due to Dissolution Failure

    Actavis Pharmaceuticals is recalling 14,856 bottles of buPROPion Hydrochloride Extended-Release Tablets 300 mg because they failed dissolution specifications during stability testing.

    Product
    buPROPion Hydrochloride Extended - Release Tablets (XL) 300 mg, 30 tablet bottles, Rx Only, NDC 67767-142-30 Actavis Distributed by: Actavis South Atlantic LLC Sunrise, FL 33325 Packaged by by: America Health Packaging Columbus, OH 43217
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-166-2013·2013-02-27

    UDL Recalls Hydrocodone and Acetaminophen Tablets Due to Potency Issues

    Mylan Institutional, Inc. is recalling specific lots of Hydrocodone Bitartrate and Acetaminophen Tablets because the tablets are oversized, resulting in superpotent assays of both active ingredients.

    Product
    Hydrocodone Bitartrate and Acetaminophen Tablets, USP, 10 mg/500 mg; 100 Tablets (5 x 20), 5 cards each containing 20 blistered tablets per carton, Rx only; Manufactured for: Qualitest Pharmaceuticals, Huntsville, AL 35811, Pkg by & Distributed by UDL Laboratories, Inc.…
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-167-2013·2013-02-27

    Crest Pro-Health Oral Rinse Recalled for Cross-Contamination

    Procter & Gamble is recalling Crest Pro-Health Oral Rinse because it was mixed with another type of mouthwash.

    Product
    Crest PRO-HEALTH CPC Antigingivitis/Antiplaque Oral Rinse, 250 mL (8.4 fl oz),Dist. by Procter & Gamble, Cincinnati, OH 45202 NDC 37000-452-02
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-161-2013·2013-02-20

    Lee Pharmaceuticals Recalls 12-Hour Sinus Nasal Spray Due to Microbial Contamination

    Lee Pharmaceuticals is recalling 12-Hour Sinus Nasal Spray products due to microbial contamination identified during testing.

    Product
    12-Hour Sinus (oxymetazoline hydrochloride) Nasal Spray, 0.05%, 1 FL OZ (30 mL), labeled as a) 12 HOUR SINUS Nasal Spray, Best Choice, Proudly Distributed By: Valu Merchandisers, Co., Kansas City, MO 64111, UPC 0 70038 61226 1; b) Nasal Spray Sinus, Distributed by Discount Drug…
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-160-2013·2013-02-20

    Upsher Smith Recalls Propranolol Hydrochloride Capsules for Dissolution Failure

    Upsher Smith Laboratories is recalling 60 bottles of Propranolol Hydrochloride Extended-release Capsules, 80 mg, due to failed dissolution test requirements.

    Product
    Propranolol Hydrochloride Extended-release Capsules, USP, 80 mg, 100 Capsules, Rx only, Manufactured for Upsher Smith Laboratories, Inc Minneapolis MN 55447 --- NDC 0245-0085-11, UPC 3 0245-0085-11 9
    Category
    Drug
    Distribution
    2 states
  • LowFDA (Drugs)·D-163-2013·2013-02-20

    Ranbaxy Recalls Lac-Hydrin Cream Due to Crystallization

    Ranbaxy Inc. is recalling specific lots of Lac-Hydrin (ammonium lactate) Cream, 12%, due to a gritty texture caused by crystallization.

    Product
    Lac-Hydrin (ammonium lactate) Cream, 12%, packaged in a) 280 g (2 x 140 g tubes), NDC 10631-099-28; b) 385 g bottle, NDC 10631-099-38; Rx only, Ranbaxy, Jacksonville, FL 32257 USA.
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-162-2013·2013-02-20

    Ranbaxy Recalls Lac-Hydrin Lotion Due to Crystallization Texture

    Ranbaxy Inc. is recalling 4,016 bottles of Lac-Hydrin Lotion, 12%, due to a gritty texture caused by crystallization.

    Product
    Lac-Hydrin (ammonium lactate) Lotion, 12%, packaged in 400 g bottles, Rx only, Ranbaxy, Jacksonville, FL 32257 USA, NDC 10631-098-14.
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-164-2013·2013-02-20

    West-ward Recalls Subpotent Glycopyrrolate Tablets in Ohio

    West-ward Pharmaceutical Corp. voluntarily recalled 1,185 bottles of Glycopyrrolate Tablets, USP, 1 mg, in Ohio due to subpotent drug content.

    Product
    Glycopyrrolate Tablets, USP, 1 mg, Rx Only, 100 tablets per bottle, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ, 07724, NDC 0143-1250-01.
    Category
    Drug
    Distribution
    1 state
  • CriticalFDA (Drugs)·D-148-2013·2013-02-13

    Globe All Wellness Recalls Slim Xtreme Capsules Containing Unapproved Sibutramine

    Globe All Wellness is recalling Slim Xtreme Herbal Slimming Capsules because testing revealed the presence of sibutramine, an unapproved and withdrawn drug.

    Product
    SLIM XTREME Herbal Slimming Capsule, supplied in 30-count bottles. Another Product Forumulated and Distributed By: Globe All Wellness, LLC Hollywood, FL 33020 www.diet66.com Inquires Call 877.842.9873
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-157-2013·2013-02-13

    Bracco Recalls Isovue-370 Injection Syringes Due to Particulate Matter

    Bracco Diagnostic Inc. is recalling specific lots of Isovue-370 injection syringes because they contain particulate matter, including cellulose and polyvinyl fibers.

    Product
    Isovue -370 (Iopamidol) Injection 76%, Prefilled 10 x 75 mL (NDC 0270-1316-66), 10 x 100 mL (NDC 0270-1316-67), 10 x 125 mL (NDC 0270-1316-68) Power Injector Syringe, Rx Only, Manufactured for Bracco Diagnostics Inc., Princeton, NJ 08543 by Nycomed GmbH 78224 Singen (Germany).
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-154-2013·2013-02-13

    Hospira Recalls Carboplatin Injection Vials Due to Visible Crystals

    Hospira is recalling 31,326 vials of Carboplatin Injection due to visible crystals found during inspection. The product is distributed nationwide and in Puerto Rico.

    Product
    CARBOPLATIN — CARBOPLATIN (CARBOPLATIN)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-147-2013·2013-02-13

    Mylan Recalls Lansoprazole Capsules Due to Foreign Topiramate Tablets

    Mylan Pharmaceuticals is recalling 1,894 bottles of lansoprazole 30 mg capsules because they may contain foreign topiramate 100 mg tablets.

    Product
    LANSOPRAZOLE — LANSOPRAZOLE (LANSOPRAZOLE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-153-2013·2013-02-13

    Hospira Recalls Carboplatin Injection Vials Due to Crystallization

    Hospira Inc. is recalling 23,315 vials of Carboplatin Injection due to visible particulates identified as Carboplatin crystals.

    Product
    CARBOPLATIN — CARBOPLATIN (CARBOPLATIN)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-158-2013·2013-02-13

    Bracco Recalls Isovue-300 Injection Syringes Due to Particulate Matter

    Bracco Diagnostic Inc. is recalling specific lots of Isovue-300 Injection syringes because they contain particulate matter identified as cellulose and polyvinyl fibers.

    Product
    Isovue -300 (Iopamidol) Injection 61% Prefilled, 10 x 100 mL Power Injector Syringe, Rx Only, Manufactured for Bracco Diagnostics Inc., Princeton, NJ 08543 by Nycomed GmbH 78224 Singen (Germany); NDC 0270-1315-67.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-155-2013·2013-02-13

    Zicam Nasal Spray Recalled for Burkholderia cepacia Contamination

    Matrixx Initiatives Inc is recalling Zicam Extreme Congestion Relief nasal spray due to potential contamination with Burkholderia cepacia. The recall covers 46,752 bottles distributed nationwide.

    Product
    Zicam Extreme Congestion Relief (oxymetazoline HCl) nasal gel, 0.05%, 0.50 fl. oz. (15 mL) spray bottle, Developed and distributed by Zicam LLC, Scottsdale, Arizona 85255, a wholly owned subsidiary of Matrixx Initiatives Inc, NDC 62750-005-10, UPC 7 32216 20410 0.
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-150-2013·2013-02-13

    West-ward Recalls Carisoprodol Tablets Due to Foreign Substance Presence

    West-ward Pharmaceutical Corp. is recalling 8,585 bottles of Carisoprodol Tablets, USP, 350 mg, due to the presence of uncharacteristic black spots on the tablets.

    Product
    Carisoprodol Tablets, USP, 350 mg, packaged in a) 500-count tablets per bottle (NDC 0143-1176-05) and b) 1000-count tablets per bottle (NDC 0143-1176-10), Rx only, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ 07724.
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-143-2013·2013-02-13

    Actelion Recalls Three Cartons of Subpotent Ventavis Inhalation Solution

    Actelion Pharmaceuticals is recalling three cartons of Ventavis (iloprost) Inhalation Solution due to an out-of-specification assay result indicating the drug was subpotent.

    Product
    Ventavis (iloprost) Inhalation Solution, 10 mcg/1 mL, Sterile, 30 Single Use Ampules per carton, Manufactured for Actelion Pharmaceuticals US, Inc, 5000 Shoreline Court, Ste 200, South San Francisco, CA 94080, NDC: 66215-302-30.
    Category
    Drug
    Distribution
    2 states